VIRMA and breast cancer: Accumulating evidence demonstrates that VIRMA is markedly overexpressed in multiple malignancies (e.g., hepatocellular carcinoma, breast cancer, colorectal cancer), where it drives tumor proliferation, invasion, and metastasis through m6A-dependent mechanisms [18,19,20].